9 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Neutropenia LOW RISK ... and clinically stable ... comorbidities HIGH RISK ... #Algorithm #Management
Alcohol-related liver disease algorithm. 

In patients in whom alcohol is suspected to be the main injurious
liver disease algorithm ... for the higher-risk ... liver fibrosis evaluation ... tailored to the device ... #algorithm #ARLD
Abnormal liver function tests algorithm.
 This figure details the initial response to abnormal liver blood tests.
function tests algorithm ... aminotransferase; ARLD ... , alcohol-related ... LFTs #Abnormal #Algorithm ... #Hepatology #Liver
Non-alcoholic fatty liver disease algorithm.
 
For those patients with NAFLD or liver disease of unknown aetiology,
liver disease algorithm ... signifying a low risk ... tailored to the device ... Disease #NAFLD #algorithm ... Referral #Management #Hepatology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Evaluation Major ... Any implantable devices ... event, follow ACC algorithm ... Stable patients ... #Evaluation #stratification
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... High-risk patient ... and clinically stable ... neutropenic #fever #IDSA ... #Algorithm #Management
Polycythemia - Differential Diagnosis Algorithm
Polycythemia itself isn’t a diagnosis. Like many things, it is a condition
Differential Diagnosis Algorithm ... How we define polycythemia ... circulation = risk ... always a good idea ... Differential #Diagnosis #Algorithm
Algorithm for choosing the appropriate candidate for stress testing in patients with suspected coronary artery disease
Algorithm for choosing ... diagnosis and risk ... guidelines for the evaluation ... of stable angina
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... instability with a risk ... of clonal evolution ... and are also at risk ... #algorithm #hematology